Suppr超能文献

[芬喹酮用于原发性高血压的中期治疗。与氢氯噻嗪和安慰剂的双盲比较]

[Fenquizone in the medium term treatment of essential hypertension. Double-blind comparison with chlorthalidone and placebo].

作者信息

Pasotti C, Rossi R, Gandolfi P

出版信息

Minerva Med. 1981 Nov 17;72(46):3105-10.

PMID:7029355
Abstract

In a double blind study, tolerability and antihypertensive effect of fenquizone were compared with those of chlorthalidone and placebo. In both mild and moderately severe essential hypertension, fenquizone and chlortalidone showed a significant antihypertensive effect; moreover, fenquizone lowered the clinostatic arterial diastolic pressure in a more gradual and continuous way. Differently from chlortalidone, fenquizone had no effects on blood levels of potassium and cholesterol.

摘要

在一项双盲研究中,比较了芬喹宗与氯噻酮及安慰剂的耐受性和降压效果。在轻度和中度严重原发性高血压患者中,芬喹宗和氯噻酮均显示出显著的降压效果;此外,芬喹宗能更逐渐且持续地降低临床静态动脉舒张压。与氯噻酮不同,芬喹宗对血钾和胆固醇水平没有影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验